hFcRn-mediated transplacental immunoglobulin G transport: Protection of and threat to the human fetus and newborn

Wiener Medizinische Wochenschrift

Volumn 162, Issue 9-10, 2012, Pages 207-213

  Ellinger, Isabella ^a   Fuchs, Renate ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoimmune antibodies; Human neonatal Fc receptor (hFcRn); Neonatal infections; Placental IgG transport; Therapeutic antibodies

Indexed keywords

ABATACEPT; ADALIMUMAB; AUTOANTIBODY; FC RECEPTOR; GOLIMUMAB; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INFLIXIMAB; NATALIZUMAB; PHOSPHOLIPID ANTIBODY; RITUXIMAB; VERY LATE ACTIVATION ANTIGEN 1;

ALLOIMMUNITY; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD PLACENTA BARRIER; ENDOTHELIUM CELL; FETUS DEVELOPMENT; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; IMMUNITY; INFECTION; MATERNAL BLOOD; PLACENTA VILLUS; PLACENTAL TRANSFER; PREGNANCY OUTCOME; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY; TRANSCYTOSIS; VERTICAL TRANSMISSION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT, NEWBORN; ISOANTIBODIES; MATERNAL-FETAL EXCHANGE; PREGNANCY; RECEPTORS, FC; TRANSCYTOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863639310     PISSN: 00435341     EISSN: 1563258X     Source Type: Journal    
DOI: 10.1007/s10354-012-0085-0     Document Type: Article

References (45)

1. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: When? Where? Why? Lancet, 365(9462):891-900, 2005.
2. Simister NE. Human placental Fc receptors and the trapping of immune complexes. Vaccine, 16:1451-1455, 1998. (Pubitemid 28364683)
3. Baker K, Qiao SW, Kuo T, et al. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin Immunopathol, 31:223-236, 2009.
4. Palmeira P, Quinello C, Silveira-Lessa AL, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Develop Immunol, 2012:985646, 2012.
5. Mayhew TM, Burton GJ. Stereology and its impact on our understanding of human placental functional morphology. Microsc Res Tech, 38:195-205, 1997. (Pubitemid 27328960)
6. Lisciandro JG, van den Biggelaar AH. Neonatal immune function and inflammatory illnesses in later life: lessons to be learnt from the developing world? Clin Exp Allergy, 40:1719-1731, 2010.
7. Palfi M, Selbing A. Placental transport of maternal immunoglobulin G. Am J Reprod Immunol, 39:24-26, 1998. (Pubitemid 27527141)
8. van den Berg JP, Westerbeek EA, van der Klis FR, et al. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev, 87:67-72, 2011.
9. Munoz FM, Englund JA. Vaccines in pregnancy. Infect Dis Clin North Am, 15:253-271, 2001. (Pubitemid 32268124)
10. Palmeira P, Costa-Carvalho BT, Arslanian C, et al. Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin. Pediatr Allergy Immunol, 20:528-535, 2009.
11. Wernick NL, Haucke V, Simister NE. Recognition of the tryptophanbased endocytosis signal in the neonatal Fc Receptor by the μ subunit of adaptor protein-2. J Biol Chem, 280:7309-7316, 2005. (Pubitemid 40341289)
12. Ward ES, Ober RJ. Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn. Adv Immunol, 1 03:77-115, 2009.
13. Ober RJ, Radu CG, Ghetie V, et al. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol, 13:1551-1559, 2001. (Pubitemid 33133882)
14. West AP Jr, Bjorkman PJ. Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complexrelated Fc receptor, hFcRn. Biochemistry, 39:9698-9708, 2000. (Pubitemid 30626819)
15. Malek A, Sager R, Kuhn P, et al. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol, 36:248-255, 1996. (Pubitemid 26383975)
16. Firan M, Bawdon R, Radu C, et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gammaglobulin in humans. Int Immunol, 13:993-1002, 2001. (Pubitemid 32750502)
17. Kristoffersen EK, Matre R. Co-localization of the neonatal Fc gamma receptor and IgGin human placental term syncytiotrophoblasts. Eur J Immunol, 26:1668-1671, 1996. (Pubitemid 26230021)
18. Szlauer R, Ellinger I, Haider S, et al. Functional expression of the human neonatal Fc-receptor, hFcRn, in isolated cultured human syncytiotrophoblasts. Placenta, 30:507-515, 2009.
19. Simister NE, Story CM, Chen HL, et al. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur J Immunol, 26:1527-1531, 1996. (Pubitemid 26229998)
20. Lyden TW, Robinson JM, Tridandapani S, et al. The Fc receptor for IgG expressed in the villus endothelium of human placenta is Fc gamma RIIb2. J Immunol, 166:3882-3889, 2001. (Pubitemid 32224914)
21. Ellinger I, Ellinger A, Leitner K, et al. IgG transport across epithelia mediated by the human neonatal Fc-receptor, hFcRn. In: Naim HY, Zimmer K-P (eds) The Brush Border Membrane - From Molecular Cell Biology to Clinical Pathology. SPS Publications, Fulda, pp. 79-121, 2006.
22. Takizawa T, Anderson CL, Robinson JM. A novel Fc gamma R-defined, IgG-containing organelle in placental endothelium. J Immunol, 175:2331-2339, 2005. (Pubitemid 41113842)
23. Leitner K, Ellinger I, Grill M, et al. Efficient apical IgG recycling and apical-to-basolateral transcytosis in polarized BeWo cells overexpressing hFcRn. Placenta, 27:799-811, 2006. (Pubitemid 43905922)
24. Schepelmann M, Heindl A, Uhrova H, et al. The neonatal IgG Fcreceptor (FcRn) is expressed in the syncytioprohpblast, fetal endothelial cells and Hofbauer cells of human term placental chorionic villi. Placenta, 32:A54, 2011.
25. Ellinger I, Fuchs R. Endosomal pH reglation in polarized BeWo cells. Placenta, 30:A84, 2009.
26. Ellinger I, Rothe A, Grill M, et al. Apical to basolateral transcytosis and apical recycling of immunoglobulin G in trophoblast-derived BeWo cells: effects of low temperature, nocodazole, and cytochalasin D. Exp Cell Res, 269:322-331, 2001.
27. Malek A, Sager R, Zakher A, et al. Transportof immunoglobulin Gand its subclasses across the in vitro-perfused human placenta. Am J Obstet Gynecol, 173:760-767, 1995.
28. Jinga VV, Grafencu A, Antohe F, et al. Establishment of a pure microvascular endothelial cell line from human placenta. Placenta, 21:325-336, 2000. (Pubitemid 30364866)
29. Antohe F, Radulescu L, Gafencu A, et al. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum Immunol, 62:93-105, 2001. (Pubitemid 32171646)
30. Sesarman A, Vidarsson G, Sitaru C. The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases. Cell Mol Life Sci, 67:2533-2550, 2010.
31. Motta M, Rodriguez-Perez C, Tincani A, et al. Neonates born from mothers with autoimmune disorders. Early Hum Dev, 85(10 Suppl):S67-S70, 2009.
32. Skogen B, Killie MK, Kjeldsen-Kragh J, et al. Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention. Expert Rev Hematol, 3:559-566, 2010.
33. Schnitzler F, Fidder H, Ferrante M, et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis, 17:1846-1854, 2011.
34. Vinet E, Pineau C, Gordon C, et al. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum, 61:587-592, 2009.
35. Hazes JM, Coulie PG, Geenen V, et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology (Oxford), 50:1955-1968, 2011.
36. Mahadevan U, Cucchiara S, Hyams JS, et al. The London position statement of the world congress of gastroenterology on biological therapy for IBD with the European crohn?s and colitis organisation: pregnancy and pediatrics. Am J Gastroenterol, 106:214-223, 2011; quiz 24.
37. Zelinkova Z, de Haar C, de Ridder L, et al. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther, 33:1053-1058, 2011.
38. Djokanovic N, Klieger-Grossmann C, Pupco A, et al. Safety of infliximab use during pregnancy. Reprod Toxicol, 32:93-97, 2011.
39. Verstappen SM, King Y, Watson KD, et al. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis, 70:823-826, 2011.
40. Hellwig K, Haghikia A, Gold R. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler, 17:958-963, 2011.
41. Cheent K, Nolan J, Shariq S, et al. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn?s disease. J Crohns Colitis, 4:603-605, 2010.
42. Arsenescu R, Arsenescu V, de Villiers WJ. TNF-alpha and the development of the neonatal immune system: implications for inhibitor use in pregnancy. Am J Gastroenterol, 106:559-562, 2011.
43. Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based consensus on the diagnosis and management of crohn?s disease: special situations. J Crohns Colitis, 4:63-101, 2010.
44. Kuo TT, Baker K, Yoshida M, et al. Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol, 30:777-789, 2010.
45. Cianga C, Cianga P, Plamadeala P, et al. Nonclassical major histocompatibility complex I-like Fc neonatal receptor (FcRn) expression in neonatal human tissues. Hum Immunol, 72:1176-1187, 2011.